Tumorigenic de-differentiation: the alternative splicing way.

Ray, Debleena; Epstein, David M

Ray, Debleena; Epstein, David M.

Ray D; Cancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
Epstein DM; Cancer & Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.

Mol Cell Oncol ; 7(6): 1809959, 2020 Sep 09.

Article en En | MEDLINE | ID: mdl-33235913

Palabras clave

JNK; JNK inhibitors; MAP2K7; MBNL1; RNA binding proteins; alternative splicing; cancer cell de-differentiation; cancer stem cells; splice factors

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671003
https://dx.doi.org/10.1080/23723556.2020.1809959

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7671003
https://dx.doi.org/10.1080/23723556.2020.1809959

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2020 Tipo del documento: Article